Shares of Tyme Technologies, Inc. (NASDAQ:TYME) have earned a consensus broker rating score of 1.00 (Strong Buy) from the three analysts that cover the stock, Zacks Investment Research reports. Three equities research analysts have rated the stock with a strong buy rating.
Analysts have set a twelve-month consensus price objective of $8.33 for the company and are forecasting that the company will post ($0.06) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Tyme Technologies an industry rank of 185 out of 265 based on the ratings given to related companies.
A number of research firms recently weighed in on TYME. BidaskClub downgraded Tyme Technologies from a “hold” rating to a “sell” rating in a research note on Friday, January 26th. Canaccord Genuity began coverage on Tyme Technologies in a research note on Wednesday, January 3rd. They issued a “buy” rating on the stock. Evercore ISI began coverage on Tyme Technologies in a research note on Friday, November 17th. They issued an “outperform” rating and a $7.00 price target on the stock. Finally, HC Wainwright started coverage on Tyme Technologies in a research note on Friday, December 15th. They issued a “buy” rating and a $8.00 price target on the stock.
Shares of Tyme Technologies (NASDAQ TYME) opened at $4.42 on Friday. Tyme Technologies has a 12 month low of $2.14 and a 12 month high of $9.50.
Tyme Technologies (NASDAQ:TYME) last posted its quarterly earnings results on Thursday, November 2nd. The company reported ($0.06) earnings per share for the quarter. equities research analysts expect that Tyme Technologies will post -0.23 EPS for the current fiscal year.
In other Tyme Technologies news, COO Michael Demurjian sold 50,000 shares of the business’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $3.34, for a total transaction of $167,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
A hedge fund recently bought a new stake in Tyme Technologies stock. Franklin Street Advisors Inc. NC bought a new position in shares of Tyme Technologies, Inc. (NASDAQ:TYME) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 31,000 shares of the company’s stock, valued at approximately $198,000. 2.45% of the stock is owned by institutional investors.
TRADEMARK VIOLATION WARNING: “Zacks: Analysts Set $8.33 Price Target for Tyme Technologies, Inc. (TYME)” was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/05/zacks-analysts-set-8-33-price-target-for-tyme-technologies-inc-tyme.html.
About Tyme Technologies
Tyme Technologies, Inc is a clinical-stage biotechnology company. The Company is focused on developing cancer therapeutics that is intended to be broadly effective across tumor types and have low toxicity profiles. The Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system.
Get a free copy of the Zacks research report on Tyme Technologies (TYME)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.